Alexis Garcia, PharmD, senior director of business development at Tabula Rasa HealthCare, explains the importance of up-to-date data when implementing medication therapy management programs.
Obtaining timely data and encouraging patient engagement are crucial to successful medication therapy management programs, said Alexis Garcia, PharmD, senior director of business development at Tabula Rasa HealthCare.
Transcript
Are different demographics more susceptible to the effects of cytochrome P450 (CYP450) enzymes?
So everybody is different and everybody can have a different response to medications based on their genetic differences. So race and ethnicity can play a role in adverse drug events. You know, some people may be ultra metabolizers. Some may be poor metabolizers. And ultimately that's going to affect the way that they process those medications.
If medication therapy management (MTM) programs help with these issues, what are some of the barriers payers face in implementing these programs?
I think some of the biggest barriers to implementing real successful MTM programs are timely data. So you want to make sure that when you're speaking to a patient that you have the most up to date information for that patient that allows you to have more impactful interventions or recommendations with that patient, but also patient engagement. So one, how can you get ahold of this patient to talk to them about their medications and establishing that trust with the patient, that you are a clinician calling on their behalf and that you do want to help them? Make sure that they are on the most safe medications and really getting optimal use from the medications that they're taking.
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More